Skip to main content
Amplitude Surgical logo

Amplitude Surgical — Investor Relations & Filings

Ticker · AMPLI ISIN · FR0012789667 LEI · 9695006Q1VL1OHK06336 PA Manufacturing
Open in API
Filings indexed 269 across all filing types
Latest filing 2023-10-18 Earnings Release
Country FR France
Listing PA AMPLI

About Amplitude Surgical

https://www.amplitude-surgical.com/en/

Amplitude Surgical is a company specializing in the design, manufacture, and marketing of surgical technologies for lower-limb orthopedics. Its primary focus is on developing high-end implants and prostheses for hip and knee replacement surgeries. The company provides a range of products, including femoral stems, acetabular cups, and total knee prostheses, along with associated instrumentation. Amplitude Surgical supports surgeons and healthcare facilities through a global distribution network composed of direct subsidiaries and exclusive distributors, aiming to restore mobility for patients through innovative orthopedic solutions.

Recent filings

Filing Released Lang Actions
Inside Information / News release on accounts, results
Earnings Release Classification · 98% confidence The document explicitly announces the company's "2022-23 annual results" on October 18, 2023. It contains detailed financial tables summarizing sales, EBITDA, operating profit, and net profit for the fiscal year ending June 30, 2023, comparing them to the previous year (2021-2022). This content structure—a comprehensive summary of full-year financial performance—is characteristic of an Annual Report or the primary release associated with it. Since the text provides the full results summary and detailed figures, it is classified as the core financial reporting document. Although it is a press release announcing the results, the depth of the financial data provided strongly suggests it is the primary disclosure of the annual figures, which aligns best with the scope of a 10-K filing, even if this specific document is the press release version of those results. Given the options, '10-K' is the most appropriate code for comprehensive annual financial results disclosure. It is not a short announcement (RPA) as it contains extensive data. FY 2023
2023-10-18 English
Informations privilégiées / Communiqué sur comptes, résultats
Earnings Release Classification · 100% confidence The document explicitly announces the 'résultats annuels 2022-23' (annual results 2022-23) for Amplitude Surgical. It contains detailed financial tables covering revenue, gross margin, EBITDA, operating income, and net income for the fiscal year, comparing 2022-23 with 2021-2022. This content structure—a comprehensive summary of full-year financial performance, including management commentary and key highlights—is characteristic of an Annual Report or the primary release associated with it. Since the document provides the full financial summary and is not merely a short announcement pointing to an attached report (the document length is substantial at 10,467 chars), it aligns best with the comprehensive nature of the Annual Report (10-K) category, even if it might be a press release version preceding the formal 10-K filing. Given the options, '10-K' is the most appropriate classification for a full annual financial results disclosure. FY 2023
2023-10-18 French
Informations privilégiées / Information sur chiffre d’affaires annuel
Earnings Release Classification · 100% confidence The document explicitly announces the 'chiffre d'affaires consolidé pour l'exercice fiscal 2022-23' (consolidated revenue for the fiscal year 2022-23) and provides detailed revenue figures for the full year and the fourth quarter (T4). This content is characteristic of an Earnings Release (ER), which provides the initial announcement of periodical financial results (key highlights). Although it mentions the upcoming 'Résultats annuels' (Annual Results) in October, this specific document is the preliminary revenue announcement for the fiscal year ending June 30, 2023. It is not the comprehensive 10-K, nor is it a transcript or a management discussion/analysis (MDA), but rather the headline figures release. FY 2023
2023-07-20 French
Acquisition ou cession des actions de l''émetteur / Information relative au contrat de liquidité
Transaction in Own Shares Classification · 95% confidence The document is titled "Amplitude Surgical : Bilan semestriel du contrat de liquidité" (Half-yearly balance sheet of the liquidity contract) and reports on the status of a liquidity contract as of June 30, 2023, detailing transactions (purchases and sales of shares) during the first half of 2023 (January 1 to June 30, 2023). This document is a periodic disclosure related to market making/liquidity management, which is a specific type of regulatory or market-related announcement. It is not a full Annual Report (10-K), an Earnings Release (ER), or a comprehensive Interim Report (IR). It specifically details transactions related to the liquidity agreement, which is a form of insider/market activity reporting, but the context is a required periodic disclosure about the liquidity provider's actions. Given the options, this type of periodic report detailing market operations under a specific agreement, often required by stock exchanges, fits best under the general 'Regulatory Filings' (RNS) category as a specific, non-standard financial report, or potentially related to 'Director's Dealing' if the liquidity provider is considered an insider, but RNS is the most appropriate general regulatory disclosure bucket when a more specific one (like DIRS or DIV) doesn't fit perfectly. Since it is a formal, periodic report on a specific agreement, RNS is the best fit among the provided codes for a miscellaneous regulatory disclosure.
2023-07-20 French
Inside Information / Information on annual revenues
Earnings Release Classification · 100% confidence The document explicitly announces the 'Consolidated sales for fiscal year 2022-23' for Amplitude Surgical, providing key financial figures (€100.2m sales, growth rates) and a CEO comment. This content structure—a press release format detailing period-specific financial performance highlights—is characteristic of an Earnings Release (ER). Crucially, it also contains a forward-looking statement: 'Next press release: Annual results 2022-23: Wednesday, October 18, 2023, after market close.' This confirms the current document is the preliminary announcement of results, not the comprehensive Annual Report (10-K) or the detailed Management Discussion & Analysis (MDA). Therefore, the classification is Earnings Release (ER). FY 2023
2023-07-20 English
Inside Information / Other news releases
M&A Activity Classification · 99% confidence The document is a press release announcing the closing of a business sale (Novastep activities) and provides a date for the next financial update (2022-23 full-year sales). It is not a full annual report (10-K), an interim report (IR), or a formal earnings release (ER) which typically contains detailed figures. It is an announcement regarding a significant corporate transaction (sale of a business unit) and future reporting schedules. Since it details a major corporate event (sale/divestiture) that impacts capital structure/financing, it aligns best with Capital/Financing Update (CAP) or potentially Regulatory Filings (RNS) if no other category fits. Given the focus on the financial impact of the sale (EUR 68 million generated, partial bond redemption), CAP is a strong candidate. However, it is primarily a corporate action announcement. Since it doesn't fit perfectly into the specific transaction types like M&A (TAR) or Share Issue (SHA), and it's a general corporate update, RNS (Regulatory Filings/General Announcement) is the safest fallback, although CAP is plausible due to the financing aspect. Given the context of a major transaction announcement, and lacking a specific 'Corporate Action' code, I will classify it as a general Regulatory Filing (RNS) as it is a material event announcement not covered by the more specific financial report codes.
2023-06-29 English

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.